Recombinant RSV antigens, nucleic acid molecules encoding the antigens, and vaccine compositions comprising the same
AssigneeNational Taiwan University
InventorsLimin Huang, Jenmin Huang
Life of this patent
Estimating the term…
Abstract
Provided is an antigen including a recombinant respiratory syncytial virus (RSV) F protein, wherein the recombinant RSV F protein includes an antigenic region flanked with an HRN region and an HRC region, and the antigenic region includes one or more antigenic sites selected from the group consisting of site Ø, site II, and site IV. The present disclosure also provides a nucleic acid molecule encoding the antigen and a vaccine composition including the antigen for eliciting an immune response against RSV.
Claims19
An antigen comprising a recombinant respiratory syncytial virus (RSV) F protein, wherein the recombinant RSV F protein comprises an antigenic region flanked with an N-terminal heptad repeat (HRN) region and a C-terminal heptad repeat (HRC) region, and wherein
- the HRN region and the HRC region comprise amino acid sequences of SEQ ID NO:
- 1 and SEQ ID NO:
- 2, respectively;
- the antigenic region comprises two or more antigenic sites selected from the group consisting of site Ø, site II, and site IV including amino acid sequences of SEQ ID NO:
- 3, SEQ ID NO:
- 4, and SEQ ID NO:
- 5, respectively;
- and
- the antigenic sites are linked to each other by a linker independently consisting of 2 to 20 amino acids.
Dependencies are inferred from the claim text.